UBS Group
SNGXW

UBS Group’s Soligenix, Inc. Warrant SNGXW Stock Holding History

UBS Group’s Portfolio SNGXW Stock Details SNGXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,700
Closed – – 11278
2021
Q3 		$0 Buy
4,700
+890
+23% +$135 ﹤0.01% 10619
2021
Q2 		$1K Buy
3,810
+346
+10% +$63 ﹤0.01% 9315
2021
Q1 		$1K Buy
3,464
+74
+2% +$24 ﹤0.01% 8879
2020
Q4 		$1K Sell
3,390
-22,461
-87% -$12.8K ﹤0.01% 8311
2020
Q3 		$16K Sell
25,851
-381
-1% -$240 ﹤0.01% 6497
2020
Q2 		$13K Buy
26,232
+22,512
+605% +$9.39K ﹤0.01% 6865
2020
Q1 		$1K Sell
3,720
-6,030
-62% -$3.64K ﹤0.01% 7864
2019
Q4 		$1K Buy
9,750
+2,750
+39% +$456 ﹤0.01% 8028
2019
Q3 		$1K Sell
7,000
-4,900
-41% -$801 ﹤0.01% 7891
2019
Q2 		$1K Buy
+11,900
New +$1.36K ﹤0.01% 7771
2018
Q1 		– Sell
-200
Closed – – 8322
2017
Q4 		$0 Buy
+200
New +$115 ﹤0.01% 8217
2017
Q3 		– Sell
-400
Closed – – 8120
2017
Q2 		$0 Sell
400
-1,100
-73% -$890 ﹤0.01% 8126
2017
Q1 		$1K Buy
+1,500
New +$808 ﹤0.01% 7497

UBS Group's SNGXW Position: Q4 2021 in Review

UBS Group sold out of Soligenix, Inc. Warrant (SNGXW) in Q4 2021, closing a stake of 4,700 shares.

UBS Group first reported a position in SNGXW in Q1 2017 and held it in 13 quarters. The position peaked at $16K in Q3 2020. 1 fund tracked by Wall St. Rank holds SNGXW as of Q4 2021.

  • UBS Group reported no remaining Soligenix, Inc. Warrant position as of Q4 2021 after selling out during the quarter.
  • UBS Group sold 4,700 Soligenix, Inc. Warrant shares in Q4 2021.
  • UBS Group first reported a position in Soligenix, Inc. Warrant in Q1 2017 and held it in 13 quarters.
  • UBS Group's Soligenix, Inc. Warrant position peaked at $16K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Soligenix, Inc. Warrant as of Q4 2021.

Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.